Biotricity (NASDAQ:BTCY) Stock Price Up 26.2% – Time to Buy?

Biotricity, Inc. (NASDAQ:BTCY)’s share price was up 26.2% on Friday . The stock traded as high as $0.40 and last traded at $0.39. Approximately 48,209 shares changed hands during mid-day trading, a decline of 20% from the average daily volume of 60,134 shares. The stock had previously closed at $0.31.

Analyst Ratings Changes

Separately, HC Wainwright restated a “neutral” rating on shares of Biotricity in a research report on Monday, November 18th.

Biotricity Stock Performance

The business’s 50-day simple moving average is $0.32 and its two-hundred day simple moving average is $0.41.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Biotricity stock. AE Wealth Management LLC bought a new position in Biotricity, Inc. (NASDAQ:BTCY) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 97,751 shares of the company’s stock, valued at approximately $88,000. AE Wealth Management LLC owned about 0.45% of Biotricity as of its most recent filing with the Securities and Exchange Commission. 3.89% of the stock is owned by institutional investors and hedge funds.

About Biotricity

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.